Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

hyperCORE International Names New President





Longtime Member and FOMAT CEO Nicholas Focil Appointed to Lead Global Research Site Network

LAKE MARY, FL, July 29, 2025 /24-7PressRelease/ -- hyperCORE International, a partner site network of clinical trial sites across North America, today announced the appointment of Nicholas Focil as its new president. Bringing nearly two decades of experience in clinical operations leadership, strategic partnerships, and expansion into emerging markets, Focil is poised to enhance hyperCORE's impact in the global clinical research space.

Focil is the founder and CEO of FOMAT Medical Research, headquartered in Oxnard, California. Under his leadership, FOMAT has grown over the past ten years, conducting Phase I–IV trials across more than 70 therapeutic areas in the U.S. and Latin America (California, Florida, Ecuador, Colombia, and Peru), with a core focus on ethical, high-quality, and diverse clinical data. FOMAT is also a charter member of hyperCORE International and has been a committed network partner for over six years. Focil's early career included investigator‑ initiated lab work with a Nobel laureate, followed by pioneering roles in pre‑pivotal diabetes device trials at Medtronic MiniMed and leadership at Diverse Research Solutions before founding FOMAT. Focil has built a reputation for promoting trial diversity and community engagement.

Outgoing president Carlos Orantes laid a strong foundation that continues to guide hyperCORE's growth.

"Passing on the baton to Nicholas Focil as the next president is an exciting milestone and evolution for the network's leadership to continue its path of excellence," Orantes shared. "I'm looking forward to working with Nicholas in his new capacity."

"I'd like to extend my heartfelt gratitude to Carlos Orantes for his dedicated service as hyperCORE's President," shared Focil. "His leadership and unwavering commitment to fostering a high-performing, inclusive network have established a robust foundation for our future endeavors. Additionally, I would like to express my appreciation to all previous presidents who have contributed to our journey; their efforts have been instrumental in shaping the organization we are today. Our partner site networks exemplify the pinnacle of operational excellence, innovation, and patient-centered care."

"Looking ahead," Focil added, "I am invigorated by the opportunity to continue building the pioneering legacy of hyperCORE. I am enthusiastic about collaborating with our partner site networks to enhance site capabilities, broaden the reach of our trials, and deliver even more diverse, high-quality research that benefits both patients and sponsors. It is a privilege to step into this role during such a dynamic period of growth and momentum for hyperCORE and clinical research as a whole."

About hyperCORE International

Founded in 2019, hyperCORE International is a partner site network of leading clinical research site organizations. Boasting over 80 active trial sites across five countries and two continents, hyperCORE's partners have jointly completed 7,000+ studies involving over 140,000 randomized participants. Each partner member operates independently but integrates harmonized operational frameworks to optimize efficiency, standardization, and excellence.

hyperCORE remains committed to advancing clinical research through safe, ethical, timely studies; efficient enrollment; and superior retention—empowered by its members' top-tier awards for performance, quality, and innovation.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.